JP2000511529A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000511529A5 JP2000511529A5 JP1997542424A JP54242497A JP2000511529A5 JP 2000511529 A5 JP2000511529 A5 JP 2000511529A5 JP 1997542424 A JP1997542424 A JP 1997542424A JP 54242497 A JP54242497 A JP 54242497A JP 2000511529 A5 JP2000511529 A5 JP 2000511529A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1879496P | 1996-05-31 | 1996-05-31 | |
| US60/018,794 | 1996-05-31 | ||
| PCT/US1997/007650 WO1997045403A1 (en) | 1996-05-31 | 1997-05-12 | Aryl substituted cyclic amines as selective dopamine d3 ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000511529A JP2000511529A (ja) | 2000-09-05 |
| JP2000511529A5 true JP2000511529A5 (cg-RX-API-DMAC7.html) | 2005-01-13 |
Family
ID=21789817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09542424A Ceased JP2000511529A (ja) | 1996-05-31 | 1997-05-12 | 選択的ドーパミンｄ３リガンドとしてのアリール置換環式アミン |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6084130A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0923542B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2000511529A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20000016147A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1159292C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE247639T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU720414B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2255612A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ370198A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69724259T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0923542T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2205227T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI982572A7 (cg-RX-API-DMAC7.html) |
| NO (1) | NO314398B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ332538A (cg-RX-API-DMAC7.html) |
| PL (1) | PL187296B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT923542E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2185372C2 (cg-RX-API-DMAC7.html) |
| SI (1) | SI0923542T1 (cg-RX-API-DMAC7.html) |
| SK (1) | SK282725B6 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1997045403A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI274750B (en) * | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
| EP1088821A1 (en) * | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
| US6410787B2 (en) | 2000-02-22 | 2002-06-25 | Pharmacia & Upjohn Company | Process to prepare 2-aminoindan derivatives |
| AU2001288329A1 (en) | 2000-09-18 | 2002-04-02 | Pharmacia Ab | Process to prepare (2s)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1h-indene-5- carboxamide |
| EP1193268A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
| HU227543B1 (en) | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
| US20050085461A1 (en) * | 2002-02-13 | 2005-04-21 | Cooper David G. | Benzenesulfonamide derivatives |
| CA2566526C (en) * | 2004-06-02 | 2012-10-23 | F. Hoffmann-La Roche Ag | Naphthaline derivatives useful as histamine-3-receptor ligands |
| MX2007004355A (es) | 2004-10-14 | 2007-07-17 | Abbot Gmbh & Co Kg | Compuestos de 6-amino (aza) indano adecuados para tratar trastornos que responden a la modulacion del receptor de dopamina d3. |
| WO2006040179A1 (en) * | 2004-10-14 | 2006-04-20 | Abbott Gmbh & Co. Kg | Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| NZ589649A (en) * | 2004-10-14 | 2012-04-27 | Abbott Gmbh & Co Kg | Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| US7851463B2 (en) | 2004-10-14 | 2010-12-14 | Abbott Gmbh & Co. Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| MX2007004358A (es) | 2004-10-14 | 2007-07-17 | Abbott Gmbh & Co Kg | Compuestos de azabicicloheptilo adecuados para tratar trastornos que responden a la modulacion del receptor de dopamina d3. |
| ES2363348T3 (es) * | 2004-10-14 | 2011-08-01 | ABBOTT GMBH & CO. KG | Compuestos aromáticos bicíclicos sustituidos con aminometilo adecuados para tratar trastornos que responden a la modulación del receptor d3 de dopamina. |
| TW200800959A (en) * | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
| EP1893617A1 (en) * | 2005-06-17 | 2008-03-05 | Wyeth a Corporation of the State of Delaware | Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists |
| AR063984A1 (es) * | 2006-11-28 | 2009-03-04 | Wyeth Corp | Metabolitos de 5-fluoro-8-{4-[4-(6-metoxiquinolin-8-il)piperazin-1-il]piperidin-1-il}quinolina, metodos de preparacion, su uso en la fabricacion de medicamentos para el tratamiento de trastornos relacionados con 5-ht1a, composicion farmaceutica que los comprende, compuestos radioetiquetados derivado |
| GB0721332D0 (en) * | 2007-10-31 | 2007-12-12 | Motac Neuroscience Ltd | Medicaments |
| GB0721333D0 (en) * | 2007-10-31 | 2007-12-12 | Motac Neuroscience Ltd | Medicaments |
| CN102786483B (zh) * | 2011-05-19 | 2016-03-30 | 复旦大学 | 4-（4-苯基哌嗪基）喹唑啉类衍生物的药用用途 |
| KR101800594B1 (ko) * | 2014-07-30 | 2017-11-22 | 에프. 호프만-라 로슈 아게 | 미량 아민 결합 수용체(taar) 조절제로서 6-아미노-5,6,7,8-테트라하이드로나프탈렌-2-일 또는 3-아미노크로만-7-일 유도체 |
| WO2018200571A1 (en) | 2017-04-25 | 2018-11-01 | Arbutus Biopharma Corporation | Substituted 2,3-dihydro-1h-indene analogs and methods using same |
| CN110041318B (zh) * | 2018-01-17 | 2022-07-29 | 中国科学院上海药物研究所 | 一类多巴胺d5受体激动剂及其制备和应用 |
| US12083118B2 (en) | 2018-03-29 | 2024-09-10 | Arbutus Biopharma Corporation | Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2752659A1 (de) * | 1976-12-07 | 1978-06-08 | Sandoz Ag | Neue tetralinderivate, ihre herstellung und verwendung |
| FR2512814A1 (fr) * | 1981-09-16 | 1983-03-18 | Synthelabo | Derives d'amino-2 tetrahydro-1,2,3,4 naphtalene, leur preparation et leur application en therapeutique |
| US4448990A (en) * | 1982-11-16 | 1984-05-15 | Eli Lilly And Company | Hydroxyaminotetralincarboxamides |
| JPS6169747A (ja) * | 1984-08-31 | 1986-04-10 | Otsuka Pharmaceut Co Ltd | ２，３―ジヒドロ―１ｈ―インデン誘導体及びその製造法 |
| DE3572485D1 (en) * | 1984-12-22 | 1989-09-28 | Thomae Gmbh Dr K | Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| US5225596A (en) * | 1989-01-09 | 1993-07-06 | The Upjohn Company | Halo substituted aminotetralins |
| EP0690843B1 (en) * | 1993-03-25 | 2000-08-30 | PHARMACIA & UPJOHN COMPANY | Formyl- or cyano- substituted indole derivatives having dopaminergic activity |
| ATE187436T1 (de) * | 1993-08-06 | 1999-12-15 | Upjohn Co | 2-aminoindane als selektive dopamin-d3-liganden |
| JP3878210B2 (ja) * | 1995-02-01 | 2007-02-07 | ファルマシア・アンド・アップジョン・カンパニー | 選択的ドーパミンｄ３リガンドとしての２−アミノインダン類 |
| EP0817767B1 (en) * | 1995-03-27 | 2000-05-24 | Smithkline Beecham Plc | Bicyclic amine derivatives and their use as anti-psychotic agents |
-
1997
- 1997-05-12 WO PCT/US1997/007650 patent/WO1997045403A1/en not_active Ceased
- 1997-05-12 CZ CZ983701A patent/CZ370198A3/cs unknown
- 1997-05-12 CA CA002255612A patent/CA2255612A1/en not_active Abandoned
- 1997-05-12 AU AU30601/97A patent/AU720414B2/en not_active Ceased
- 1997-05-12 PT PT97925470T patent/PT923542E/pt unknown
- 1997-05-12 KR KR1019980709715A patent/KR20000016147A/ko not_active Ceased
- 1997-05-12 CN CNB971943265A patent/CN1159292C/zh not_active Expired - Fee Related
- 1997-05-12 EP EP97925470A patent/EP0923542B1/en not_active Expired - Lifetime
- 1997-05-12 ES ES97925470T patent/ES2205227T3/es not_active Expired - Lifetime
- 1997-05-12 RU RU98123954/04A patent/RU2185372C2/ru not_active IP Right Cessation
- 1997-05-12 DK DK97925470T patent/DK0923542T3/da active
- 1997-05-12 JP JP09542424A patent/JP2000511529A/ja not_active Ceased
- 1997-05-12 SK SK1488-98A patent/SK282725B6/sk unknown
- 1997-05-12 AT AT97925470T patent/ATE247639T1/de not_active IP Right Cessation
- 1997-05-12 DE DE69724259T patent/DE69724259T2/de not_active Expired - Fee Related
- 1997-05-12 SI SI9730586T patent/SI0923542T1/xx unknown
- 1997-05-20 US US08/859,587 patent/US6084130A/en not_active Expired - Fee Related
-
1998
- 1998-11-02 NZ NZ332538A patent/NZ332538A/en unknown
- 1998-11-02 PL PL97330207A patent/PL187296B1/pl not_active IP Right Cessation
- 1998-11-27 FI FI982572A patent/FI982572A7/fi not_active IP Right Cessation
- 1998-11-30 NO NO19985599A patent/NO314398B1/no not_active Application Discontinuation